These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Academic medical centers and conflicts of interest. Meador KJ JAMA; 2006 Jun; 295(24):2845; author reply 2848-9. PubMed ID: 16804144 [No Abstract] [Full Text] [Related]
24. Philanthropy, ethics, and leadership in academic psychiatry. Roberts LW; Coverdale J; Louie AK Acad Psychiatry; 2006; 30(4):269-72. PubMed ID: 16908601 [No Abstract] [Full Text] [Related]
25. Role of Leaders in Fostering Meaningful Collaborations Between Academic Medical Centers and Industry While Also Managing Individual and Institutional Conflicts of Interest. Pizzo PA; Lawley TJ; Rubenstein AH JAMA; 2017 May; 317(17):1729-1730. PubMed ID: 28464157 [No Abstract] [Full Text] [Related]
26. Academic medical centers and conflicts of interest. Goldblum OM; Franzblau MJ JAMA; 2006 Jun; 295(24):2845-6; author reply 2848-9. PubMed ID: 16804142 [No Abstract] [Full Text] [Related]
28. Insurer joins hospital board . . . expert questions wisdom of Beth Israel appointment. Vesely R Mod Healthc; 2007 Dec; 37(50):14. PubMed ID: 18203369 [No Abstract] [Full Text] [Related]
29. Why academic medical centers should ban drug company gifts to individuals. Strong C Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327 [No Abstract] [Full Text] [Related]
31. Academic medical centers and conflicts of interest. Ting JY JAMA; 2006 Jun; 295(24):2846; author reply 2848-9. PubMed ID: 16804146 [No Abstract] [Full Text] [Related]
32. Drug reps and the academic medical center: a case for management rather than prohibition. Huddle TS Perspect Biol Med; 2008; 51(2):251-60. PubMed ID: 18453729 [TBL] [Abstract][Full Text] [Related]
33. Boardroom disclosure. In light of recent corporate scandals, AHA board execs debate whether they should serve on the boards of for-profit companies. Galloro V Mod Healthc; 2002 Dec; 32(48):8-9, 12-4, 3. PubMed ID: 12510626 [TBL] [Abstract][Full Text] [Related]
35. How to restore the fiduciary relationship. An interview with Eliot Spitzer. Interview by Louise O'Brien. Spitzer E Harv Bus Rev; 2004 May; 82(5):70-7, 150. PubMed ID: 15146737 [TBL] [Abstract][Full Text] [Related]
36. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
37. Capitalize on expertise. Three for-profits tap healthcare executives for boards. Becker C Mod Healthc; 2006 Feb; 36(8):14. PubMed ID: 16515219 [No Abstract] [Full Text] [Related]
38. Using your Web site as an accountability tool. Peregrine MW; Schwartz JR Trustee; 2004 May; 57(5):24-5. PubMed ID: 15181772 [No Abstract] [Full Text] [Related]
39. Contact with pharmaceutical representatives: where does prudence lead? Appelbaum PS Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326 [No Abstract] [Full Text] [Related]
40. Double dipping, no ethics. Executives and their associations caught up in same pattern of conflicts. Burda D Mod Healthc; 2006 Feb; 36(6):23. PubMed ID: 16515087 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]